Arzu funda Tarhan

Dr. Arzu funda Tarhan


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MÇMERT ÇELİK
MERT ÇELİK
ATArzu funda Tarhan
Arzu funda Tarhan
AŞAykut Şahin
Aykut Şahin
FDFatih Enes Durmaz
Fatih Enes Durmaz
Objective: Serum albumin/creatinine ratio (sACR) integrates nutritional–inflammatory status and renal reserve. We evaluated its ability to predict 1-year reintervention for symptomatic graft occlusion in patients undergoing prosthetic above-knee femoropopliteal bypass for peripheral artery disease (PAD). Methods: This single-center retrospective study included 132 adults (7 women, 125 men) who underwent Dacron above-knee femoropopliteal bypass. The primary analysis evaluated preoperative sACR as a continuous variable. For descriptive comparisons and Kaplan–Meier visualization, patients were stratified according to the median preoperative sACR value (3.77), yielding two groups: <3.77 vs. ≥3.77. The primary endpoint was reintervention for symptomatic graft occlusion confirmed by imaging. Discrimination was assessed using ROC analysis, and the ROC-derived cutoff was interpreted as an exploratory threshold rather than a validated clinical decision point. Associations with 1-year reintervention were assessed using Cox proportional hazards regression analysis (age, diabetes, hypertension, smoking, coronary artery disease, hemodialysis-dependent chronic kidney disease, hemoglobin level, GFR, total protein level, antiplatelet use, and anticoagulant use). Results: Most baseline characteristics were comparable between groups; however, hemodialysis-dependent chronic kidney disease was more frequent in the low-sACR group. Reintervention occurred significantly more often in the low-sACR group from month 1 onward. sACR significantly discriminated 1-year events (AUC = 0.736; p < 0.001). The optimal cutoff was ≤3.7 (sensitivity 90.9%, specificity 64.6%). Higher sACR was associated with lower 1-year event risk in both univariate and multivariate models (adjusted HR 0.61, 95% CI 0.43–0.87; p = 0.007). Conclusions: Preoperative sACR is a practical biomarker associated with early and 1-year reintervention risk after prosthetic above-knee femoropopliteal bypass and may aid perioperative risk stratification.